Buchu Research

Watch the video of Professor Patrick Bouic below to get an in-depth perspective on how buchu works as an anti-inflammatory.

 

 

 

Research : Certificates

Patent No: 20032849                Cass No: 84649-9              Einics No: 2910479

Fema/Gras: 2169                       FDA No: 172.510

 

buchu research  
Research
  • British Pharmacopoeia, 1914
  • Martindale. The Extra Pharmacopoeia, 1977
  • Merck Index 1976 USA
  • Newall CA et al, Herbal Medicines, London 1996
  • Scott Medical Journal; 43(6): 189-191
  • Bouic P, 2000
  • M. I. Lambert / T. Burgess / T. D. Noakes, 2004
  • Galley P, Thiollet M. Pubmed: 8376915; Mar 1993;12(1):69-72. 

 

 

Research : Published Articles and Clinical Trials

 

Wessel Kriek and Prof. Patrick Bouic of Synexa Life Sciences   Wessel Kriek and Prof. Patrick Bouic at Synexa Life Sciences researching the wonders of buchu during a lab session in 2008.

 

SYNOPSIS OF RESEARCH
by Prof. Patrick Bouic
Reduction of chronic pain. Reduction of inflammation. Use in Arthritis, Rheumatism and any other joint destroying process. Use in cases of cystitis, prostatitis, pyelonephritis. Prevention of swelling and bruising.
Read more
EFFICACY OF BUCHU IN TREATING SYMPTOMS OF PAIN AND SWELLING
by Lambert Burgess Noakes
Buchulife Group had significantly less swelling of the excercised arm compared to the placebo group. This difference was pronounced and of clinical relevance. In conclusion, the treatment with BuchuLife Topical Gel reduced the swelling in the damaged muscle
Read more
A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A NEW VENO-ACTIVE FLAVONOID FRACTION (S 5682) IN THE TREATMENT OF SYMPTOMATIC CAPILLARY FRAGILITY
by P. Galley and M. Thiolett - Service de Médecine Interne, Hôpital de Pessac, France
Diosmin has shown to help strenthen blood vessels and prevent four different types of bruising. Diosmin is one of the main components in Buchu.
Read more
BIOLOGICAL EFFICACY OF BUCHU EXTRACT
by Prof. Patrick Bouic - Head of Immunology Stellenbosch University
BuchuLife is a POTENT INHIBITOR of the oxidative burst, inhibiting this response by 67% at a 1:400 dilution. BuchuLife extract has NO significant inhibitory effects on the expression of CD11b/CD18
Read more
BUCHU – Agathosma betulina and Agathosma crenulata (Rutaceae)
by A. Moolla and A.M. Viljoen
The toxicity of Agathosma betulina and Agathosma crenulata was evaluated by Moolla and Viljoen. The extracts of Agathosma betulina and Agathosma crenulata were not toxic at the concentrations tested.
Read more

Industry Partners

 

 

    Synexa Life Sciences